Work

Prognostic impact of actionable driver alterations and efficacy of targeted therapy in lung squamous cell carcinoma: A large-scale nationwide genomic screening (LC-SCRUM-Asia).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.8631

Authors: Tetsuya Sakai, Hiroki Izumi, Shingo Matsumoto, Shuji Murakami, Kazumi Nishino, Daisuke Arai, Jun Sugisaka, Saori Takata, Shoichi Kuyama, Jun Sakakibara-Konishi, Ikue Kamei, Eriko Tabata, Naoki Furuya, Shingo Miyamoto, Masahiro Kodani, Haruko Daga, Yuto Motobayashi, Koichi Goto

Institutions: National Cancer Center Hospital East, Kanagawa Cancer Center, Osaka International Cancer Institute, Saiseikai Utsunomiya hospital, Sendai Kousei Hospital, Kyorin University, Iwakuni Medical Center, Hokkaido University, Itami City Hospital, Ikeda Municipal Hospital, St. Marianna University School of Medicine, Japanese Red Cross Medical Center, Tottori University, Osaka City General Hospital, Yokohama City University Medical Center, Yokohama City University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Takeda Pharmaceutical Company, Boehringer Ingelheim Japan, Ono Pharmaceutical, Pfizer Japan, MSD K.K., Eli Lilly Japan, Daiichi Sankyo Company, Novartis Japan, Medical and Biological Laboratories

OpenAlex ID: W7162492490

Cites:

Cited by: 1

Related to: 10